We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
(-3.4%)
Cap. Flow
-$21B
Cap. Flow
% of AUM
-11.12%
Top 10 Holdings %
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$826M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$813M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$305M |
| 4 |
Microsoft
MSFT
|
+$261M |
| 5 |
Pinterest
PINS
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$1.08B |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$1.02B |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$843M |
| 5 |
Linde
LIN
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.66% |
| 2 | Healthcare | 11.06% |
| 3 | Financials | 8.17% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Communication Services | 6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Camden National
CAC
$1.01B
| $487K | ﹤0.01% |
10,205
-710
| -7% | -$33.7K |
|
3727
Lucid Motors
LCID
$3.04B
| $487K | ﹤0.01% |
+1,852
| New | +$406K |
|
|
LL
3728
DELISTED
LL Flooring Holdings, Inc.
LL
| $487K | ﹤0.01% |
23,250
-7,485
| -24% | -$176K |
|
|
HIII
3729
DELISTED
Hudson Executive Investment Corp. III Class A Common Stock
HIII
| $487K | ﹤0.01% |
+50,000
| New | +$490K |
|
|
BPYU
3730
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $487K | ﹤0.01% |
25,773
-71,855
| -74% | -$1.31M |
|
3731
Central Garden & Pet Co
CENT
$2.76B
| $486K | ﹤0.01% |
11,505
-5,994
| -34% | -$269K |
|
3732
Construction Partners
ROAD
$6.03B
| $486K | ﹤0.01% |
15,500
-2,494
| -14% | -$78.3K |
|
3733
Manitowoc
MTW
$519M
| $485K | ﹤0.01% |
20,492
-9,767
| -32% | -$233K |
|
|
PRPC
3734
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $485K | ﹤0.01% |
+49,770
| New | +$491K |
|
3735
DXP Enterprises
DXPE
$2.65B
| $484K | ﹤0.01% |
14,565
-645
| -4% | -$19.9K |
|
3736
Pulmonx
LUNG
$87M
| $484K | ﹤0.01% |
+10,955
| New | +$477K |
|
3737
Rekor Systems
REKR
$94.9M
| $484K | ﹤0.01% |
47,733
+11,728
| +33% | +$180K |
|
|
CIR
3738
DELISTED
CIRCOR International, Inc
CIR
| $483K | ﹤0.01% |
14,871
-349
| -2% | -$12.3K |
|
3739
Travere Therapeutics
TVTX
$5.21B
| $482K | ﹤0.01% |
33,075
-2,518
| -7% | -$49.7K |
|
|
PAE
3740
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $482K | ﹤0.01% |
54,229
+6,562
| +14% | +$56.4K |
|
3741
Citius Pharmaceuticals
CTXR
$17.1M
| $481K | ﹤0.01% |
+5,527
| New | +$332K |
|
3742
Ternium
TX
$9.88B
| $481K | ﹤0.01% |
12,719
-2,318
| -15% | -$88.4K |
|
|
ZOM
3743
DELISTED
Zomedica Corp.
ZOM
| $479K | ﹤0.01% |
574,869
+561,709
| +4,268% | +$523K |
|
3744
PC Connection
CNXN
$2.19B
| $478K | ﹤0.01% |
10,328
-4,543
| -31% | -$213K |
|
3745
MiMedx Group
MDXG
$622M
| $477K | ﹤0.01% |
+38,114
| New | +$413K |
|
3746
iShares US Transportation ETF
IYT
$2.31B
| $476K | ﹤0.01% |
7,324
-113,076
| -94% | -$7.56M |
|
3747
Vanguard Total International Stock ETF
VXUS
$158B
| $476K | ﹤0.01% |
7,237
+1,025
| +17% | +$67.1K |
|
|
MRC
3748
DELISTED
MRC Global
MRC
| $475K | ﹤0.01% |
51,194
-18,117
| -26% | -$184K |
|
3749
Organogenesis Holdings
ORGO
$305M
| $475K | ﹤0.01% |
+28,619
| New | +$533K |
|
3750
PUT
Nutanix
NTNX
$16.6B
| $474K | ﹤0.01% |
12,400
-66,400
| -84% | -$2.07M |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q2 2021 Portfolio in Review
As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.
- Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
- Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
- Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
- Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
- Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
- Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
- Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.
Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.